Adagio Therapeutics (ADGI) stock price was up around 86% today. The clinical-stage biopharmaceutical company focuses on antibody-based solutions for infectious diseases. Currently, it is developing "ADG20" for the treatment and prevention of Covid-19. NRX Pharmaceuticals (NRXP) stock price was up 20% today. The clinical-stage small molecule pharmaceutical company stock spiked today following news of its ZYESAMI Covid-19 treatment. Finally, George Tsilis discusses Surgery Partners (SGRY) as the stock was upgraded to buy from hold at Stifel with a $51 price target.
Market On Close
29 Nov 2021
SHARE
Trading 360
28 Sep 2022
Market On Close
03 Oct 2022
Market On Close
28 Sep 2022
Trading 360
22 Sep 2022
Market On Close
10 Nov 2022
The Watch List
28 Sep 2022